Back to Search Start Over

Inclisiran: Where Are We on Safety, Efficacy, and Clinical Effectiveness of siRNA Therapies for Prevention?

Authors :
Ballantyne CM
Minhas AMK
Orringer CE
Source :
Journal of the American College of Cardiology [J Am Coll Cardiol] 2023 Dec 12; Vol. 82 (24), pp. 2262-2264.
Publication Year :
2023

Abstract

Competing Interests: Funding Support and Author Disclosures Dr Ballantyne has received institutional grant/research support and consulting fees from Novartis. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Subjects

Subjects :
Humans
RNA, Small Interfering therapeutic use
Treatment Outcome
Proprotein Convertase 9 genetics
Hypercholesterolemia drug therapy
Anticholesteremic Agents therapeutic use

Details

Language :
English
ISSN :
1558-3597
Volume :
82
Issue :
24
Database :
MEDLINE
Journal :
Journal of the American College of Cardiology
Publication Type :
Report
Accession number :
38057067
Full Text :
https://doi.org/10.1016/j.jacc.2023.10.020
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details